FIGURE

Fig. 3

ID

ZDB-FIG-210603-20

Publication

Zhou et al., 2020 - The multifaceted role of protein kinase CK2 in high-risk acute lymphoblastic leukemia

Other Figures

All Figure Page

Back to All Figure Page

Fig. 3

CK2? overexpression alone cannot maintain acute lymphoblastic leukemia in the absence of aberrant MYC activation. (A) Diagram of the experimental design. (B, top panel) Thymic fluorescence in MYC-ER (left) and MYC-ER;CK2?wt (right) zebrafish raised in 129 nM 4-hydroxytamoxifen (4HT) for 5 weeks showing tumor initiation in MYC-ER;CK2?wt fish. (B, middle panel) shows both MYC-ER (left) and MYC-ER;CK2?wt (right) with aggressive disease at 11 weeks although MYCER; CK2?wt fish developed more aggressive ALL than MYC-ER fish. (B, bottom panel) shows thymic fluorescence 4 weeks after 4HT withdrawal. One representative fish is shown for each group. (C) Zebrafish were classified by the indicated tumor phenotype at 8 weeks post 4HT removal (P=0.13; MYC-ER vs. MYCER; CK2?wt; n=11 per group). The difference in observed tumor phenotypes between each group as a whole was statistically insignificant, as calculated by a two-way ANOVA test. Scale bars =1 mm. ALL: acute lymphoblastic leukemia.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Haematologica